The IPO8 Knockout HT29 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population in which the IPO8 (importin 8) gene is disrupted, generating a loss-of-function model for dissecting nucleocytoplasmic transport mechanisms. This product is supplied as a heterogeneous pool of HT29 cells carrying gene-disrupting edits, allowing researchers to study the functional consequences of IPO8 ablation without clonal selection artifacts.
The HT29 cell line is a well-characterized human colorectal adenocarcinoma line with epithelial morphology, originally isolated from a primary tumor. It serves as a robust model system for intestinal epithelial biology, colorectal cancer research, and drug response studies. HT29 cells retain key signaling pathways relevant to carcinogenesis, including active Wnt/??-catenin, TGF-??, and NF-??B cascades, making them particularly suitable for investigating the impact of nucleocytoplasmic trafficking regulators on these networks.
IPO8 encodes a nuclear import receptor of the importin beta superfamily that binds cargo proteins via nuclear localization signals and translocates them through the nuclear pore complex in a RanGTP-dependent manner. It interacts with Ran GTPase, nucleoporins, and cargoes including NF-??B p65, SMAD2/3, ??-catenin, histones, and viral proteins like HIV-1 integrase and influenza nucleoprotein. Upstream, IPO8 is regulated by Ran??s nucleotide state and phosphorylation; downstream, it controls nuclear import of transcription factors, thereby influencing NF-??B, TGF-??, and Wnt signaling, as well as host?Cpathogen interactions.
In HT29 colorectal cancer cells, IPO8 knockout is expected to impair the nuclear accumulation of key signaling effectors, thereby attenuating transcriptional programs dependent on NF-??B, TGF-??/SMAD, and Wnt/??-catenin. This disruption can lead to reduced proliferation, altered apoptosis, diminished migration, and modified inflammatory cytokine production. The polyclonal knockout model retains genetic heterogeneity, providing a more physiologically relevant context for studying tumor behavior compared to clonal lines.
This polyclonal knockout product supports diverse applications, including nucleocytoplasmic transport studies, cancer signaling analysis, viral entry research, and drug resistance investigations. Representative assays encompass nuclear/cytoplasmic fractionation with western blotting, immunofluorescence for localization, luciferase reporter assays for NF-??B or TGF-?? activity, RNA-seq, co-immunoprecipitation, and functional tests such as proliferation, apoptosis, migration, and chemosensitivity (e.g., 5-FU, oxaliplatin). For additional technical details, please contact Ascent Research.
